Stockreport

Vir Biotechnology Announces Clinical Advances Across Hepatitis Delta and Hepatitis B Programs at AASLD's The Liver Meeting® 2024 [Yahoo! Finance]

Vir Biotechnology, Inc.  (VIR) 
PDF These data will be presented in an oral presentation at the upcoming American Association for the Study of Liver Diseases (AASLD) The Liver Meeting ® , in San Diego, CA [Read more]